Product Name: Human MAG Antibody (Refanezumab, Research Use)
Catalog Number: NBR-0241
Target Name: MAG
Trade Name: Refanezumab
Antibody Drug Description: Refanezumab is an anti-human MAG therapeutic antibody for the recovery of motor function after stroke. It is also known as GSK249320 and developed by GlaxoSmithKline. Refanezumab has been investigated in the treatment of some diseases such as cerebrovascular accident and ischaemic attack. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: MA
Synonyms: GGMA; S-MAG; SIGLEC-4A; SIGLEC4A
Target Description: Adhesion molecule that mediates interactions between myelinating cells and neurons by binding to neuronal sialic acid-containing gangliosides and to the glycoproteins RTN4R and RTN4RL2 (By similarity).
Ensembl: ENSG00000105695 
Uniprot: P20916